The rising need for protein-based treatments (biologics), the high frequency of lifestyle diseases, infectious diseases, and genetic disorders, and increased financing for protein research are all contributing to the market’s rise. High market consolidation, which raises entry barriers, and the high cost of protein treatment, on the other hand, are the key issues limiting the industry’s growth.
The expression vectors market is predicted to increase at a CAGR of 5.5 percent from 2015 to 2020, reaching $317.1 million from $242.7 million in 2015.
North America dominates this market, with the United States accounting for a significant portion of the total. The Asian market, on the other hand, is expected to increase at the fastest rate throughout the projection period. Factors such as significant growth in the pharmaceutical and biotechnology sectors, the presence of key market players in the area, and changing legislative frameworks to promote innovation and commercialization will drive expansion in the Asian market.
Thermo Fisher Scientific, Inc. (United States), Promega Corporation (United States), Sigma-Aldrich Corporation (United States), Agilent Technologies (United States), Bio-Rad Laboratories (United States), New England Biolabs (United States), Merck Millipore (United States), QIAGEN (Netherlands), Clontech Laboratories, Inc. (United States), DNA2.0 (Uni (U.S.).
The Report’s Scope
The market is segmented by host type, application, end user, and region in this study.
Type of Host
Expression Vectors for Bacteria
Expression Vectors for E. Coli
Bacterial Expression Vectors (Other Bacterial Expression Vectors)
Expression Vectors for Mammalian Organisms
Expression Vectors for CHO
Other Expression Vectors for Mammalian Organisms
Vectors for Insect Expression
Expression Vectors for Baculoviruses
Other Vectors for Insect Expression
Expression Vectors for Yeast
Expression Vectors from K. Lactis
Expression Vectors for Pichia Pastoris
Expression Vectors for Saccharomyces Cerevisiae
Other Expression Vectors for Yeast
Additional Expression Vectors
by way of application
Applications in Medicine
Applications of Research
Applications in Industry
By the End User
Biotechnology and pharmaceutical companies
Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) are two types of contract research organisations (CMOs)
Institutes of Academic Research
End Users from Other Industries
Region by Region
North America is located in North America.
U.S.
Canada
Europe
Asia
The World at Large (RoW)
A plasmid or virus utilised for protein expression in many types of host cells is known as an expression vector/expression construct. An expression vector assists in the introduction of a gene of interest into a target cell and activates the cell’s mechanism to manufacture the gene’s protein. This is a slow-growing market, with demand for protein-based medications (biologics) increasing, as well as the high frequency of lifestyle diseases, infectious diseases, and genetic abnormalities, as well as increased financing for protein research and protein treatment. High market consolidation, which raises entry barriers, and the high cost of protein treatment, on the other hand, are the key issues limiting the industry’s growth. High development potential in emerging economies, on the other hand, presents fresh growth chances for market participants.
The expression vectors market is predicted to increase at a CAGR of 5.5 percent from 2015 to 2020, reaching $317.1 million from $242.7 million in 2015. This market is divided into host type, application, end user, and region segments.
This market is divided into bacterial, mammalian, insect, yeast, and other expression vectors based on host type. E. Coli expression vectors and other bacterial expression vectors are separated from bacterial expression vectors. The market for mammalian expression vectors is further divided into CHO expression vectors and other mammalian expression vectors. The insect expression vectors market is divided into two categories: Baculovirus expression vectors and other insect expression vectors. Expression vectors for K. lactis systems, Pichia pastoris systems, Saccharomyces cerevisiae systems, and other yeast systems make up the yeast expression vectors market.
This global market is divided into therapeutic, research, and industrial applications based on application. Pharmaceutical and biotechnology firms, contract research organisations (CROs) and contract manufacturing organisations (CMOs), academic research institutes, and other end users are the market’s end users.
Annual Reports, SEC Filings, Investor Presentations, World Bank, World Intellectual Property Organization, Industry Canada, International Federation of Pharmaceutical Manufacturers & Associations, Centre for Drug Research (CDR), President’s Council of Advisors on Science and Technology, Nature Biotechnology Journal on Next-Generation Protein Drugs, Human Proteome Organization, Expert Interviews, and MarketsandMarkets Analysis are all sources.
North America leads the global market, followed by Europe, Asia, and the Rest of the World (RoW). During the projection period, North America will continue to lead the market. Asia, on the other hand, is expected to develop at the fastest rate during the predicted period. Growth in Asia is expected to be centred on China and India over the next five years.
Thermo Fisher Scientific, Inc. (United States), Promega Corporation (United States), Sigma-Aldrich Corporation (United States), Agilent Technologies (United States), Bio-Rad Laboratories (United States), New England Biolabs (United States), Merck Millipore (United States), QIAGEN (Netherlands), Clontech Laboratories, Inc. (United States), DNA2.0 (Uni (U.S.).
Leave a Reply